Protagen AG Achieves ISO 13485 Certification
News Jun 24, 2015
Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has received the ISO 13485 certification, and now officially complies with the internationally recognized quality standard for medical devices.
The certificate demonstrates that Protagen has successfully implemented a quality management system that conforms to the world-wide standard for medical device and diagnostic manufacturing.
Stefan Müllner, Protagen CEO, stated, "We have been ISO 9001 certified for some years now. The addition of the new ISO 13485 certification clearly shows our continued commitment to the highest level of quality management and design controls. This guarantees the development and production of safe and effective products and services and our international customer base can be assured that the products we are delivering are of the highest standards. The ISO 13485 criteria will provide a quality foundation upon which we and our partners will develop new diagnostic products."
The ISO (International Organization for Standardization) is the world's largest developer and publisher of International Standards. Receipt of ISO 13485 certification confirms Protagen's ongoing commitment to meeting the requirements of its customers and regulatory bodies.
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019